// App-Quantinova.ai

3568 : Neurotoxicity Profile of Vincristine Sulfate Liposome Injection (VSLI, Marqibo) Monotherapy in Adults with Relapsed Acute Lymphoblastic Leukemia and Universal Prior Standard Vincristine Exposure

Researchers

Presenter

  • Steven Deitcher

Principal Investigators

  • Jeffrey A Silverman

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Talon Therapeutics,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Peripheral neuropathy

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Constipation

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

Drug/Treatment

  • Vincristine

Outcome

  • N/A

Study Design

  • pharmacokinetics

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved